Trenton, November 7, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, issued the following statement concerning yesterday’s White House announcement on weight loss drugs:
“New Jersey’s life sciences will continue negotiating with all stakeholders on ways to lower costs for patients that don’t jeopardize our ability to discover the next generation of life-saving treatment and cures.” Buteas continued, “Today’s announcement also showcases that we are an essential part of the healthcare system that reduces long-term costs by focusing on prevention of chronic disease, and the tremendous costs we help the system avoid as we find new ways to keep people healthy and out of hospitals.”